OGN:NYSE
Organon & Co
USD 13,90
arrow_upward
+0,04%(+0,0050) 1D
USD 13,90
arrow_downward
-0,02% (-0,0021)bedtimeAfter hours
Closed: 13 Nov., 16:00:03 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
USD 13,90
High
USD 13,90
Low
USD 13,88
Mkt. cap
3,65 mjd
Avg. vol.
2,46 m
Volume
4,00 m
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,08
52-wk high
USD 13,90
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
Open
USD 13,90
High
USD 13,90
Low
USD 13,88
Mkt. cap
3,65 mjd
Avg. vol.
2,46 m
Volume
4,00 m
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,08
52-wk high
USD 13,90
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
News stories
From web sources and news partners
Benzinga
·
1 uur gelede
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
BigGo Finance
·
8 uur gelede
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
3 uur gelede
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Traders Union
·
5 uur gelede
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 k
Founded1923
HeadquartersJersey City, New Jersey, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com